Feishen Lin
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- Antimicrobial Resistance in Staphylococcus
- COVID-19 Clinical Research Studies
-
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Tuberculosis Research and Epidemiology 5
- Antimicrobial Resistance in Staphylococcus 1
-
- Mycobacterium research and diagnosis 3
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Co-authors
- Lan Yao (1 shared paper)Xia Zhang (1 shared paper)Shenjie Tang (1 shared paper)Xiaohui Hao (1 shared paper)Meiying Wu (1 shared paper)Yidian Liu (1 shared paper)Jin Gu (1 shared paper)Xin Liu (1 shared paper)
- Journals
- BMC Infectious Diseases (2 papers)Clinical Chemistry (1 paper)European Respiratory Journal (1 paper)PLoS ONE (1 paper)Quantitative Imaging in Medicine and Surgery (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Feishen Lin
9 papers receiving 223 citations
Peers
Comparison fields: 5 of 66
- Infectious Diseases 184
- Epidemiology 93
- Applied Microbiology and Biotechnology 3
- Molecular Medicine 7
- Surgery 60
Countries citing papers authored by Feishen Lin
This map shows the geographic impact of Feishen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feishen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feishen Lin more than expected).
Fields of papers citing papers by Feishen Lin
This network shows the impact of papers produced by Feishen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feishen Lin. The network helps show where Feishen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Feishen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 119 | |
| 2 | 2015 | 51 | |
| 3 | 2020 | 36 | |
| 4 | 2021 | 9 | |
| 5 | 2015 | 8 | |
| 6 | Monitoring of imipramine imi and desipramine dmi in patients with panic and phobic disorders | 1988 | 4 |
| 7 | 2024 | 2 | |
| 8 | Comparison of clinical efficacy and adverse effects between extended-release felodipine and atenolol in patients with mild and moderate essential hypertension. | 1997 | 1 |
| 9 | Comparison of clinical efficacy and adverse effects between extended-release felodipine and slow-release diltiazem in patients with isolated systolic hypertension. | 1999 | 1 |
| 10 | 2025 | 0 |
About Feishen Lin
Feishen Lin is a scholar working on Infectious Diseases, Epidemiology, Surgery, Molecular Biology and Neurology, having authored 10 papers that have together received 231 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (5 papers), Infectious Diseases and Tuberculosis (3 papers), Mycobacterium research and diagnosis (3 papers), Long-Term Effects of COVID-19 (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Blood disorders and treatments (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Blood Pressure and Hypertension Studies (1 paper). The work is most often cited by research in Infectious Diseases (184 citations), Epidemiology (93 citations), Applied Microbiology and Biotechnology (3 citations), Molecular Medicine (7 citations) and Surgery (60 citations). Feishen Lin has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Lan Yao, Xia Zhang, Shenjie Tang, Xiaohui Hao, Meiying Wu, Yidian Liu, Jin Gu, Xin Liu, Zhanjun Zhang and Gang Liu. Their work appears in journals such as BMC Infectious Diseases, Clinical Chemistry, European Respiratory Journal, PLoS ONE and Quantitative Imaging in Medicine and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.